{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:59:00Z","timestamp":1772265540539,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Ann Plast Surg"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Collagenase <jats:italic toggle=\"yes\">Clostridium histolyticum<\/jats:italic> (CCH) injection, an effective enzymatic fasciotomy treatment for Dupuytren disease (DD), was abruptly withdrawn from the healthcare market outside the United States in 2020. The impact on patients, physicians and hospitals of this helpful surgical alternative no longer being available has been little studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>To investigate the impact of the withdrawal of CCH in Japan, we used the National Database Open Data Japan from 2014 to 2020. Published by the government, it contains summary data of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. We extracted the numbers of CCH injections with Xiaflex, the product name in Japan, and surgeries identified by \u201cDupuytren contracture surgery codes.\u201d Each treatment was further parsed into one of 12 predefined regions in which it had taken place and by whether it had been delivered on an inpatient or outpatient basis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>From its introduction in 2015, the number of DD patients treated with CCH increased in each successive year, reaching a peak in 2019, while the number of surgeries decreased with time. After the withdrawal in 2020, the number of surgeries increased to 1.5 times the 2019 number notwithstanding the impact of COVID-19, but the total number of patients treated decreased by 43%. In the initial regional analysis, CCH accounted for approximately 40% of all DD treatments in the less populous areas, with the exception of the Tohoku region, and more than 50% in the other regions. By 2019, the share of CCH treatment had increased in all regions. There was no significant correlation between the number of hand surgeons authorized to use CCH and the number of CCH cases within each region.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CCH increased treatment options for patients and surgeons. The withdrawal of this valuable pharmaceutical resulted in an increase in the number of surgeries amidst a decrease in the total number of treatments and lost opportunities for patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sap.0000000000004076","type":"journal-article","created":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T17:00:10Z","timestamp":1723827610000},"page":"44-50","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Collagenase Injection on Dupuytren Disease Treatment in Japan"],"prefix":"10.1097","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8444-4941","authenticated-orcid":false,"given":"Hidemasa","family":"Yoneda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Curley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,8,12]]},"reference":[{"key":"bib1-20241212","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13018-020-01999-7","article-title":"The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis","volume":"15","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"bib2-20241212","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1142\/S2424835521500235","article-title":"Epidemiology of Dupuytren's disease in Japanese general population","volume":"26","year":"2021","journal-title":"J Hand Surg Asian Pac Vol"},{"key":"bib3-20241212","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00402-016-2448-2","article-title":"The efficacy of open partial aponeurectomy for recurrent Dupuytren's contracture","volume":"136","year":"2016","journal-title":"Arch Orthop Trauma Surg"},{"key":"bib5-20241212","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/jhsu.2000.6918","article-title":"Enzyme injection as nonsurgical treatment of Dupuytren's disease","volume":"25","year":"2000","journal-title":"J Hand Surg Am"},{"key":"bib6-20241212","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren's contracture","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"bib7-20241212","first-page":"e13527","article-title":"Second cycle of intralesional collagenase clostridium histolyticum for Peyronie's disease using the modified shortened protocol: results from a retrospective analysis","volume":"52","year":"2020","journal-title":"Andrologia"},{"key":"bib8-20241212","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41443-021-00469-w","article-title":"Is there a line between ethics and market competition? Lights and shades of the withdrawal of collagenase treatment for Peyronie's disease","volume":"34","year":"2022","journal-title":"Int J Impot Res"},{"key":"bib9-20241212","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41443-020-0271-3","article-title":"Collagenase clostridium histolyticum is no longer available in Europe: what does this mean for our patients with Peyronie's disease?","volume":"33","year":"2021","journal-title":"Int J Impot Res"},{"key":"bib11-20241212","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jos.2020.07.022","article-title":"Trends in arthroplasty in Japan by a complete survey, 2014\u20132017","volume":"26","year":"2021","journal-title":"J Orthop Sci"},{"key":"bib12-20241212","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jos.2022.06.005","article-title":"Questionnaire survey about the effects of new lifestyles during the pandemic of COVID-19 on upper limb diseases","volume":"28","year":"2023","journal-title":"J Orthop Sci"},{"key":"bib13-20241212","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/17531934221093925","article-title":"The impact of COVID-19 pandemic on hand surgery: a FESSH perspective","volume":"47","year":"2022","journal-title":"J Hand Surg Eur Vol"},{"key":"bib14-20241212","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhsg.2022.12.004","article-title":"Quantifying the impact of COVID-19 on hand and wrist surgery procedural volume: a national analysis of 381,046 cases","volume":"5","year":"2023","journal-title":"J Hand Surg Glob Online"},{"key":"bib15-20241212","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jhsa.2017.03.003","article-title":"Injectable collagenase versus percutaneous needle fasciotomy for Dupuytren contracture in proximal interphalangeal joints: a randomized controlled trial","volume":"42","year":"2017","journal-title":"J Hand Surg Am"},{"key":"bib16-20241212","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jhsa.2016.06.014","article-title":"Comparison of treatment outcome after collagenase and needle fasciotomy for Dupuytren contracture: a randomized, single-blinded, clinical trial with a 1-year follow-up","volume":"41","year":"2016","journal-title":"J Hand Surg Am"},{"key":"bib17-20241212","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/PRS.0000000000001320","article-title":"Collagenase clostridium histolyticum versus limited fasciectomy for Dupuytren's contracture: outcomes from a multicenter propensity score matched study","volume":"136","year":"2015","journal-title":"Plast Reconstr Surg"},{"key":"bib18-20241212","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1038\/s41598-022-12966-z","article-title":"The CeCORD-J study on collagenase injection versus aponeurectomy for Dupuytren's contracture compared by hand function and cost effectiveness","volume":"12","year":"2022","journal-title":"Sci Rep"},{"key":"bib19-20241212","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/17531934211043307","article-title":"Dupuytren's disease: using needles more across the world","volume":"47","year":"2022","journal-title":"J Hand Surg Eur Vol"},{"key":"bib20-20241212","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jhsg.2018.12.005","article-title":"Cost per episode of care with collagenase clostridium histolyticum versus fasciectomy for Dupuytren contracture: a real-world claims database analysis","volume":"1","year":"2019","journal-title":"J Hand Surg Glob Online"},{"key":"bib21-20241212","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(11)60987-2","article-title":"Cost containment and quality of care in Japan: is there a trade-off?","volume":"378","year":"2011","journal-title":"Lancet"}],"container-title":["Annals of Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T13:00:55Z","timestamp":1734008455000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/SAP.0000000000004076"}},"subtitle":["A Comprehensive Survey of Trends"],"short-title":[],"issued":{"date-parts":[[2024,8,12]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/sap.0000000000004076","relation":{},"ISSN":["1536-3708","0148-7043"],"issn-type":[{"value":"1536-3708","type":"electronic"},{"value":"0148-7043","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,12]]}}}